Case study describing the use of Renastep as on oral nutritional supplement as part of the dietary management of a patient with Acute Kidney Injury (AKI).
Age:16 years
Gender: Female
Diagnosis:
Acute Kidney Injury (AKI) with hypercalcaemia. Background of Trisomy 21 and oral aversion.
Relevant History:
Patient was admitted following routine blood tests having been found to be in AKI. At the time of admission it was unknown if there was a background of Chronic Kidney Disease (CKD) or evolving AKI with unknown cause. The patient was given IV fluids, with serum and urinary investigations.
Anthropometry:
Weight on admission: 27.3kg <0.4th centile*
Current weight: 36.7kg 2nd centile*
Height on admission: 128cm 0.4th centiles*
Current height: 131.2cm 0.4th-2nd centile*
Feeding history:
Only managing porridge with milk and the occasional yogurt at school. Fluid intake is poor.
Plan:
Meet energy and protein requirements whilst managing potassium and phosphate intake by reducing the patients intake of cow’s milk and using Renastep and a juice based oral nutritional supplement (ONS) instead.
Nutritional Requirements:
EAR based on weight on admission = 1201kcal/day
EAR based on ideal body weight of 55.3kg = 2430 kcals/day
Protein: 45.4g/day
12-20 mmol Ca/day
The patient was regularly reviewed in clinic; she was keen to take more porridge at home and had started taking yogurts at school. Her kidney function was improving; her serum potassium and phosphate levels had normalised. Her family were making 5 bowls of porridge per day for her; 3 bowls made with 125mls of Renastep per bowl, 1 with juice-based ONS, and 1 with cow’s milk.
It was felt that the patient could eat more so the family were advised to make any additional bowls of porridge with a non-calcium-fortified plant-based milk alternative.
Six months after admission:
Once the patients serum potassium and phosphate levels normalised, Renastep was discontinued.
Cow’s milk and yogurts have been increased to meet LRNI for calcium.
The use of Renastep enabled a reduction in potassium and phosphate intake which meant the patients serum potassium and phosphate levels returned to be within the reference range.
Renastep is 2kcal/ml which resulted in energy and protein being provided whilst limiting potassium and phosphate intake – this was an ideal way to provide nutrition support for this patient.
Renastep can be taken as a drink, added to foods or used in recipes. .